牛牛AI助手已提取核心信息
On March 6, 2024, Avenue Therapeutics, Inc. announced that a majority of its capital stock's voting power approved a discretionary grant to its board of directors to effectuate a reverse stock split. The approved range for the reverse stock split is between 30-for-1 and 75-for-1, with the board authorized to determine the exact ratio. The decision was made through a written consent signed by holders of 3,133,886 shares of common stock and 250,000 shares of Class A Preferred Stock. This represents approximately 56% of the voting power as of the consent date. The board also approved the reverse stock split and will file an amendment to the company's Third Amended and Restated Certificate of Incorporation with the Delaware Secretary of State. A Schedule 14C information statement will be filed with the SEC and provided to the company's stockholders.
On March 6, 2024, Avenue Therapeutics, Inc. announced that a majority of its capital stock's voting power approved a discretionary grant to its board of directors to effectuate a reverse stock split. The approved range for the reverse stock split is between 30-for-1 and 75-for-1, with the board authorized to determine the exact ratio. The decision was made through a written consent signed by holders of 3,133,886 shares of common stock and 250,000 shares of Class A Preferred Stock. This represents approximately 56% of the voting power as of the consent date. The board also approved the reverse stock split and will file an amendment to the company's Third Amended and Restated Certificate of Incorporation with the Delaware Secretary of State. A Schedule 14C information statement will be filed with the SEC and provided to the company's stockholders.
2024 年 3 月 6 日，Avenue Therapeutics, Inc. 宣布，其大部分股本的投票权批准了向其董事会提供全权授权，以实现反向股票分割。反向股票拆分的批准范围在30比1和75比1之间，董事会有权确定确切的比率。该决定是通过3,133,886股普通股和25万股A类优先股的持有人签署的书面同意书做出的。截至同意之日，这约占投票权的56％。董事会还批准了反向股票拆分，并将向特拉华州国务卿提交对公司第三次修订和重述的公司注册证书的修正案。附表14C信息声明将提交给美国证券交易委员会，并提供给公司的股东。
2024 年 3 月 6 日，Avenue Therapeutics, Inc. 宣布，其大部分股本的投票权批准了向其董事会提供全权授权，以实现反向股票分割。反向股票拆分的批准范围在30比1和75比1之间，董事会有权确定确切的比率。该决定是通过3,133,886股普通股和25万股A类优先股的持有人签署的书面同意书做出的。截至同意之日，这约占投票权的56％。董事会还批准了反向股票拆分，并将向特拉华州国务卿提交对公司第三次修订和重述的公司注册证书的修正案。附表14C信息声明将提交给美国证券交易委员会，并提供给公司的股东。
有用
没用